ProQR Therapeutics
@ProQR
Followers
2K
Following
512
Media
341
Statuses
884
Developing medicines using our proprietary Axiomer RNA-editing technology platform $PRQR #RNA #biotech #Axiomer #RNAediting
Leiden, Nederland
Joined February 2012
Great to connect with the local community at the Dutch Medicines Summer Afternoon! . Our VP Axiomer Science, Lenka van Sint Fiet, demonstrated how #Axiomer is driving progress toward potentially transformative therapies. #RNAEditing #DutchBioScienceWeek
0
0
5
As R&D Team Manager at ProQR, Lorenza drives scientific collaboration and project planning while also championing inclusivity as part of our DEI team. Meet the ProQR team at: #Axiomer #RNAEditing #TeamProQR
0
0
11
We are happy to announce the submission of a CTA to the EMA to initiate a Phase 1 clinical trial in healthy volunteers for AX-0810 targeting NTCP. Check out the press release for more details: #Axiomer #RNAEditing #BiotechNews
0
4
9
At ProQR, we’re proud to foster a culture where everyone feels safe to be themselves. To celebrate #Pride, our DEI team hosted a rainbow themed coffee & collaboration event with multicoloured cakes and a movie night featuring an LGBTQIA+ film and discussion. #RNAEditing #Axiomer
0
0
4
This week we held our biannual Axiomer Summit event – a day of vibrant discussions, insightful presentations, and an engaging poster session focused on our science. Thanks to our Scientific Advisory Board and Board members for joining this exciting exchange!. #RNAEditing #Axiomer
0
0
2
From Amsterdam to New Orleans to San Diego – the month of May brought many connections with the field at #EASL, #ASGCT2025, and #TIDESUSA. Posters and presentations from ASGCT and TIDES are available on our website under Presentations and Publications.
0
0
3
Great catching up with @BiotechTVHQ at #ASGCT2025! Check out this clip featuring our CSO, Gerard Platenburg, as he shares how decades of expertise in oligonucleotides helps drive innovation in our Axiomer RNA editing platform and pipeline.
𝐀𝐒𝐆𝐂𝐓 𝟐𝟎𝟐𝟓: The Co-Founder of @ProQR discusses the company's Axiomer RNA base editing technology - which will see a CTA filed this quarter and data by the end of the year. $PRQR #ASGCT2025 . Full video:
0
0
2
Today we announced our First Quarter Operating and Financial Results. Read the press release here: . $PRQR #RNAEditing #Axiomer
0
1
4
ProQR is officially a Great Place to Work!. We’re proud to foster a culture where innovation, collaboration, and growth thrive—driven by our amazing team and our mission to develop transformative RNA therapies. #GPTW #Biotech #RNAEditing #Axiomer
0
0
1
We’re excited to welcome Dennis Hom as CFO and Dr. Cristina Lopez Lopez as CMO to drive the next phase of growth. Their leadership comes at a pivotal time as we prepare to advance our Axiomer™ RNA editing platform into the clinic. #RNAediting #leadership
0
0
3
This week, CSO Gerard Platenburg and Chief ADAR Scientist Peter Beal joined the #RNAEditing Gordon Research Conference in Lucca, Italy. Gerard presented on advancing #Axiomer RNA editing for liver and CNS applications. Find the pres here:
0
1
6
Today we announced our results for the year ended December 31, 2024 and shared a business update. Read the full press release here: $PRQR #biotech #Axiomer #RNAediting
0
1
5
Coffee, connections, and celebrating women’s achievements! This week, our team came together for #IWD2025 at our monthly coffee & collaboration event. Learn more about life at ProQR: #InternationalWomensDay #Axiomer #RNAediting
0
0
1
Today marks the 10th anniversary of International Day of Women and Girls in Science. At ProQR, we are proud to celebrate our brilliant #WomeninScience, as they share their insights and reflect on their scientific journeys. #RNAediting #Axiomer #WomeninSTEM
0
0
4
Event reminder – ProQR’s Virtual Investor & Analyst Event starts in ~1 hour (10 am EST, Dec 11). Join at: #RNAEditing $PRQR
0
0
5
ProQR and Rett Syndrome Research Trust expand partnership with $8.1 M from RSRT to advance Axiomer for Rett Syndrome. Read more: #RNAEditing #Axiomer #RettSyndrome $PRQR.
proqr.com
ProQR is a clinical stage biotech company based in the Netherlands that discovers and develops unique RNA-based therapies for severe genetic disorders.
0
2
15
Today we are pleased to announce Dr. Peter Beal as our Chief ADAR Scientist. Read more:. #RNAEditing #Axiomer
0
2
16
ProQR is hosting a Virtual Analyst & Investor Event on Dec 11 at 10 am EST. Learn about the latest in our Axiomer RNA editing platform and pipeline. For more info and to register: #RNAEditing #Axiomer #Biotech $PRQR.
0
1
14
A big thanks to our Scientific Advisory Board and Board Members for joining our recent Axiomer Summit! This internal event was packed with insightful presentations, vibrant scientific discussions, and an exciting poster session. #RNAediting #AxiomerSummit
0
0
9
On a recent Saturday, ProQRians and their families gathered for lab tours, science scavenger hunts, and more fun as part of "ProQR Family Day". A big thanks to all who helped make the day so special. Here’s to more moments of connection and celebration! ❤️
0
0
4